Topiramate in patients with learning disability and refractory epilepsy.
about
Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesity.Topiramate in long-term treatment of epilepsy in the intellectually disabled.
P2860
Topiramate in patients with learning disability and refractory epilepsy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Topiramate in patients with learning disability and refractory epilepsy.
@en
Topiramate in patients with learning disability and refractory epilepsy.
@nl
type
label
Topiramate in patients with learning disability and refractory epilepsy.
@en
Topiramate in patients with learning disability and refractory epilepsy.
@nl
prefLabel
Topiramate in patients with learning disability and refractory epilepsy.
@en
Topiramate in patients with learning disability and refractory epilepsy.
@nl
P2860
P50
P1433
P1476
Topiramate in patients with learning disability and refractory epilepsy.
@en
P2093
Kevin Kelly
P2860
P304
P356
10.1046/J.1528-1157.2002.47401.X
P577
2002-04-01T00:00:00Z